Skip to content

Clinical trials

Hemophilia A trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Country / region: South Korea Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20123
20132
20142
20153
20161
20171
20188
20195
20204
20213
20223
20235
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Active, not recruiting6
Recruiting6
Enrolling by invitation2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
Novo Nordisk A/S7
Baxalta now part of Shire5
Bayer5
Hoffmann-La Roche5
BioMarin Pharmaceutical4
Genzyme, a Sanofi Company4
Bioverativ, a Sanofi company2
GC Biopharma Corp1
Green Cross Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A45
Hemophilia B11
Blood Coagulation Disorders7
Hematologic Diseases7
Blood Coagulation Disorders, Inherited6
Coagulation Protein Disorders6
Genetic Diseases, Inborn6
Hemorrhagic Disorders6
Hemostatic Disorders4
Hemorrhage3

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.